PRESENTATIONS & ENGAGEMENTS
CLEARED CERSI engages extensively across regulators, industry, academia, standards organisations and global health partners. Activity spans national and international presentations, advisory roles, standards development and collaborative forums, supporting regulatory science across the full diagnostics lifecycle.
12th February 2025
British In Vitro Diagnostics Association (BIVDA) Meeting
4th March 2025
UK CEiRSI Webinar: Case studies of CM&S for regulatory applications
25th March 2025
MHRA Implementing the UK CERSIs, delivering the future of regulatory science
8th April 2025
CLEARED CERSI and Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics, led by University of Liverpool Meeting
30th April – 1st May 2025
CLEARED CERSI MEMTAB 2 Day Conference, MEMTAB - Methods for Evaluating Models, Tests And Biomarkers
29th April – 1st May 2025
Methods for Evaluating Models, Tests And Biomarkers (MEMTAB). 7th International Conference. University of Birmingham
6th May 2025
Centre for Advanced Diagnostic Development and Application (CADDA)
8th May 2025
UCL Regulatory Medicine conference
16th May 2025
Medicines and Healthcare products Regulatory Agency (MHRA), Joseph Burt, Head of Diagnostics, Nadine Neale Diagnostic Regulatory Specialist, Innovative Devices, Healthcare, Quality and Access group
1st July 2025
Meeting with Indian Manufacturers
7th - 9th July 2025
ACT-IVD was invited to India by the Indian Institute of Medical Science (ICMR) and the Gates Foundation.
14th July 2025
Annual ABHI Parliamentary Reception at the Houses of Parliament
18th July 2025
Medicines and Healthcare products Nadine Neale Diagnostic Regulatory Specialist, Innovative Devices, Healthcare, Quality and Access group
15th August 2025
Medicines and Healthcare products Regulatory Agency (MHRA), Joseph Burt, Head of Diagnostics, Nadine Neale Diagnostic Regulatory Specialist, Innovative Devices, Healthcare, Quality and Access group
13th August 2025
Ed Middleton (MHRA) - CLEARED CERSI
15th August 2025
Medicines and Healthcare products Regulatory Agency (MHRA), Joseph Burt, Head of Diagnostics
1st September 2025
IVDR Performance Evaluation - A Roadmap for Innovators
11th September 2025
CH/212 Committee for IVDs
16th September 2025
Medicines and Healthcare products Regulatory Agency (MHRA) Performance Evaluation Assessments Team
19th September 2025
Medicines and Healthcare products Regulatory Agency (MHRA), Joseph Burt, Head of Diagnostics, Nadine Neale Diagnostic Regulatory Specialist, Innovative Devices, Healthcare, Quality and Access group
30th September - 1st October 2025
Precision Medicine: Redefining the Future of Healthcare, London UK
September 2025
EURAMET - European Association of National Metrology Institutes
2nd October 2025
SafeGen
2nd October 2025
Meeting with MHRA Post-market Benefit and Risk Assessors for IVD devices team
6th October 2025
Business Finland Ambassadors Reception - Accelerating British-Finnish collaboration on Digital Health
22nd October 2025
Meeting with Andrew Riches-Duit, Head of Biochemistry Team at MHRA South Mimms research lab.
24th October 2025
Medicines and Healthcare products Regulatory Agency (MHRA), Joseph Burt, Head of Diagnostics, Nadine Neale Diagnostic Regulatory Specialist, Innovative Devices, Healthcare, Quality and Access group
31st October 2025
Meeting with Prof Henry Potts (RADIANT CERSI)
20th November 2025
GUIDE DTCT: Guidance for the Regulation, Evaluation, Marketing and Monitoring of Direct-To-Consumer Tests (DTCTs)
21st November 2025
CLEARED CERSI Plans and Progress
26th November 2025
MHRA organised in person cross CERSI meeting (London)
9th December 2025
Presentation at NIHR HRC Methods Working Groups Collaboration and Networking Meeting. HRC are NIHR HealthTech Research Centres.